MO25-3 Long time follow-up data of first-line pembrolizumab for advanced NSCLC patients with PD-L1 TPS of 50% or greater
Saved in:
Published in | Annals of oncology Vol. 32; p. S313 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Ltd
01.07.2021
|
Online Access | Get full text |
Cover
Loading…
ISSN: | 0923-7534 1569-8041 |
---|---|
DOI: | 10.1016/j.annonc.2021.05.626 |